CS logo
small CS logo
Bezirkskrankenhaus Kufstein

Kufstein, Austria
Krankenhaus

About Bezirkskrankenhaus Kufstein


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Bezirkskrankenhaus Kufstein


During the past decade, Bezirkskrankenhaus Kufstein conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Bezirkskrankenhaus Kufstein" #1 collaborator was "Bezirkskrankenhaus Kufstein" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "ClinAssess GmbH" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

Clinical Trials Conditions at Bezirkskrankenhaus Kufstein


According to Clinical.Site data, the most researched conditions in "Bezirkskrankenhaus Kufstein" are "Subjective Tinnitus" (2 trials), "COVID-19" (1 trials), "Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Recurrent Ovarian Carcinoma" (1 trials). Many other conditions were trialed in "Bezirkskrankenhaus Kufstein" in a lesser frequency.

Clinical Trials Intervention Types at Bezirkskrankenhaus Kufstein


Most popular intervention types in "Bezirkskrankenhaus Kufstein" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Neramexane mesylate" (2 trials), "ACE inhibitor, angiotensin receptor blocker" (1 trials), "CTCAE rating" (1 trials) and "CY-503" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Bezirkskrankenhaus Kufstein


The vast majority of trials in "Bezirkskrankenhaus Kufstein" are 5 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Bezirkskrankenhaus Kufstein


Currently, there are NaN active trials in "Bezirkskrankenhaus Kufstein". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Bezirkskrankenhaus Kufstein, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Bezirkskrankenhaus Kufstein, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".